ASX News Health Care Island Pharma’s anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happy Island Pharma has reported witnessing anti-dengue 'activity' in Phase 2a readout results of its ISLA-101 drug. 2 mins27 November 2024 10:20 (AEST)